We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.
Hormone Replacement Therapy · All 50 States
The most effective treatment for menopause symptoms is hormone therapy. This is the full map: how HRT works, which form fits which woman, what it costs, how to start it online today, and how newer science — metabolic therapy and peptide research — sits alongside it.
Start your visit — $79/mo →DIRECT ANSWER
Hormone replacement therapy replaces the estradiol — and, if you have a uterus, the progesterone — your ovaries stop producing. For most healthy women under 60 or within ten years of their final period, guideline bodies including NAMS and ACOG conclude the benefits outweigh the risks. Transdermal estradiol with nightly micronized progesterone is the most common modern starting point, and it can be prescribed by a licensed clinician through telehealth in all 50 states, usually without bloodwork.
Intake from home, clinician review within one business day, prescription shipped from a licensed U.S. pharmacy. All 50 states.
How online HRT works →Patches, gels, pills, vaginal estrogen, progesterone, combination products — how each is dosed and who each suits.
Browse HRT guides →What is available where you live: prescribing rules, pharmacy access, Medicaid coverage, and licensed clinicians.
Find your state →When hormone testing actually changes the plan — and when symptoms alone are the diagnosis under NAMS 2022.
See lab options →Menopause weight gain is metabolic, not willpower. How GLP-1 therapy fits beside hormone therapy.
GLP-1 guide →Research-grade peptide education — mechanisms, literature, and safety context. Educational, not a prescribed therapy.
Explore the library →There is no single best HRT — there is the form that matches your symptoms, your medical history, and your life. This is how clinicians actually choose.
| Form | How it is taken | Best suited to | Clinical note |
|---|---|---|---|
| Estradiol patch | Transdermal, changed 1–2× weekly | First-line for most women; avoids first-pass liver metabolism | Lowest VTE signal among estrogen routes in observational data |
| Estradiol gel / spray | Daily to skin | Women who react to patch adhesive or want fine dose control | Transdermal, same first-pass advantage as patches |
| Oral estradiol | Daily tablet | Simplicity, low cost, no skin reactions | Passes through the liver — discussed case-by-case with risk factors |
| Vaginal estrogen | Cream, insert, or ring | Dryness, painful sex, recurrent UTIs — local symptoms | Minimal systemic absorption; can be used alongside systemic HRT |
| Micronized progesterone | Nightly capsule | Anyone with a uterus taking systemic estrogen (endometrial protection) | Bioidentical progesterone; often improves sleep |
| Testosterone (off-label) | Low-dose transdermal | Persistent low desire after estrogen is optimized | No FDA-approved female product in the U.S.; prescribed selectively |
Full detail: online HRT, step by step · cost and insurance · how HRT works in the body
Deeper reading: side effects · cancer risk data · the window of opportunity · report a side effect
Peptides are the most hyped category in longevity medicine, and the honest position is this: they are not a replacement for hormone therapy. HRT has randomized outcome data, FDA-approved products, and guideline backing. Most peptides discussed online are research compounds with preclinical or early-phase evidence and no FDA approval for menopause symptoms.
So we publish peptides as science, not as a prescription pathway: mechanisms, the actual literature, safety and legal context, and a plain statement of what is unknown. If a compound ever earns clinical standing, our patients will read it here first — with the evidence attached.
HRT-adjacent peptides: educational hub → · Peptide therapy guide → · Peptide library A–Z → · Are peptides safe? →
Start where it actually hurts. Each guide covers the mechanism, what helps, and a realistic timeline on treatment.
Sleep breaks in perimenopause for three overlapping reasons: night sweats fragment sleep, falling progesterone removes a…
Read the guide →Systemic estrogen therapy reduces hot flash frequency and severity by roughly 75–90 percent and is the most effective tr…
Read the guide →Perimenopause carries a genuine increase in risk for depressive symptoms, and transdermal estradiol has randomized evide…
Read the guide →Hormone therapy is not a weight-loss treatment, and it is dishonest to sell it as one. What estradiol does do is shift f…
Read the guide →Brain fog in the menopause transition is real and measurable — verbal memory and processing speed dip during perimenopau…
Read the guide →Treat pain before desire. Vaginal estrogen is the most effective treatment for dryness, painful sex, and recurrent urina…
Read the guide →Estradiol patch vs. gel vs. pill vs. vaginal estrogen: how clinicians actually choose
Compare options →Micronized progesterone vs. synthetic progestins vs. the IUD: choosing endometrial protection
Compare options →Testosterone in perimenopause and menopause: what the evidence supports, and what it does not
Compare options →Non-hormonal alternatives to HRT: fezolinetant, SSRIs, gabapentin, CBT, and what actually works
Compare options →Hormone replacement therapy (HRT), also called menopausal hormone therapy, replaces the estrogen — and, when a uterus is present, the progesterone — that declines during perimenopause and menopause. It is the most effective treatment for hot flashes, night sweats, sleep disruption, and genitourinary symptoms, and it preserves bone density.
For most healthy women under 60 or within 10 years of their final period, guideline bodies including NAMS and ACOG conclude the benefits of systemic HRT outweigh the risks. Risk depends on age, time since menopause, route of estrogen, the progestogen used, and personal history. Contraindications include a history of breast cancer, active clotting disease, unexplained vaginal bleeding, and severe liver disease.
Usually yes. For women over 45 with typical symptoms, menopause is a clinical diagnosis based on symptoms and menstrual history — routine hormone testing is not required to start therapy. Labs are ordered when there is a specific reason, such as symptoms under age 45, thyroid concerns, or cardiometabolic risk assessment.
They are different categories. HRT is FDA-approved prescription hormone replacement with decades of outcome data. Peptides are a broad class of short amino-acid chains, most of which are research compounds without FDA approval for menopause. Kindr treats peptides as an education-first science library, not a substitute for hormone therapy.
There is no fixed stop date. Current guidance supports individualized duration: continuing therapy as long as benefits outweigh risks for you, reassessed at least annually with your clinician. Vaginal estrogen can typically be continued indefinitely.
Systemic estrogen reduces bone loss and fracture risk and is FDA-approved for osteoporosis prevention. Cardiovascular effects depend on timing: starting near menopause is associated with more favorable outcomes than starting many years later. HRT is not prescribed solely for heart disease prevention.
The Kindr visit is $79 for the first month, then $89 per month, and includes clinician review, prescription, and ongoing messaging. Medication is billed separately by the pharmacy; generic estradiol is frequently under $30 per month, and many insurance plans cover HRT.
A board-certified clinician licensed in your state reviews your intake within one business day and builds your plan around the evidence on this page.
Start your visit — $79/mo →Comparing providers? How to choose an HRT telehealth provider →
Medically reviewed by Kindr Health Clinical Team
Kindr Health Inc. — Editorial & Clinical Team (physician-supervised)
NPI 1609792902 · Last reviewed: July 3, 2026
WRITTEN & MEDICALLY REVIEWED BY
Kindr Health Inc. — Editorial & Clinical Team (physician-supervised)
Kindr’s clinical content is written and reviewed by board-certified clinicians who prescribe hormone therapy every day across all 50 states — menopause-focused physicians, nurse practitioners, and pharmacists working under Kindr Health, Inc.’s organizational clinical oversight. Every page is checked against current NAMS and ACOG guidance, FDA labeling, and the primary literature before publication, then re-reviewed on a rolling schedule when guidance changes.
Organizational NPI 1609792902 · Last reviewed July 3, 2026 · Editorial policy
Educational content only — not a substitute for individual medical advice, diagnosis, or treatment.
SOURCES & REFERENCES
Information on this page is for educational purposes only. Prescription medications require clinical evaluation and provider approval. Individual results vary. Not an emergency service.